Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study

BACKGROUND: The aim of this study was to prospectively analyse, for the first time worldwide by in vivo clinical confocal microscopy (CCM), corneal side effects secondary to the use of epidermal growth factor receptor (EGFR) inhibitor depatuxizumab mafodotin (ABT-414) in a cohort of patients affecte...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ther Adv Med Oncol
Autores principales: Parrozzani, Raffaele, Lombardi, Giuseppe, Midena, Edoardo, Leonardi, Francesca, Londei, Davide, Padovan, Marta, Caccese, Mario, Marchione, Giulia, Bini, Silvia, Zagonel, Vittorina, Frizziero, Luisa
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7278095/
https://ncbi.nlm.nih.gov/pubmed/32550861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920907543
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares